(Z)-2-(3-hydroxy-4-methoxybenzyl-idene)-1-azabicyclo[2.2.2]octan-3-one

Acta Crystallographica Section C: Crystal Structure Communications

Volumn 59, Issue 11, 2003, Pages

  Sonar, Vijayakumar N ^a   Parkin, Sean ^b   Crooks, Peter A ^a  

^a University of Kentucky   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDES; CHEMICAL BONDS; CONDENSATION; CONFORMATIONS; CRYSTAL STRUCTURE; CRYSTALLINE MATERIALS; CRYSTALLIZATION; METHANOL; MOLECULAR STRUCTURE; SYNTHESIS (CHEMICAL); X RAY CRYSTALLOGRAPHY;

AZABICYCLIC RING SYSTEM; HYDROXYMETHOXYBENZALDEHYDE; HYDROXYMETHOXYBENZYLIDENE;

NITROGEN COMPOUNDS;

2 (3 HYDROXY 4 METHOXYBENZYLIDENE) 1 AZABICYCLO(2.2.2)OCTAN 3 ONE; 2-(3-HYDROXY-4-METHOXYBENZYLIDENE)-1-AZABICYCLO(2.2.2)OCTAN-3-ONE; DOPAMINE; DRUG DERIVATIVE; GUAIACOL; OCTANE; QUINUCLIDINE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

CRYSTALLOGRAPHY, X-RAY; DOPAMINE; GUAIACOL; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; OCTANES; QUINUCLIDINES;

EID: 0345603498     PISSN: 01082701     EISSN: None     Source Type: Journal    
DOI: 10.1107/S0108270103022339     Document Type: Article

References (19)

1. Bencherif, M., Schmitt, J. D., Bhatti, B. S., Crooks, P. A., Caldwell, W. S., Lovette, M. E., Fowler, K., Reeves, L. & Lippiello, P. M. (1998). J. Pharmacol. Exp. Ther. 284, 886-894.
2. Britton, D. R., Curzon, P., Mac-Kenzie, R. G., Kebabian, J. W., Williams, J. E. G. & Kerkman, D. (1991). Pharmacol. Biochem. Behav. 39, 911-915.
3. Corrigall, W. A. & Coen, K. M. (1991). Pharmacol. Biochem. Behav. 39, 799-802.
4. Grady, S., Grun, E. U., Marks, M. J. & Collins, A. C. (1997). J. Pharmacol. Exp. Ther. 282, 32-43.
5. Holladay, M. W., Dart, M. J. & Lynch, J. K. (1997). J. Med. Chem. 40, 4169-4194.
6. Mello, N. K. & Negus, S. S. (1996). Neuropsychopharmacology, 14, 375-424.
7. Mullen, G., Napier, J., Balestra, M., DeCory, T., Hale, G., Macor, J., Mack, R., Loch, J. III, Wu, E., Kover, A., Verhoest, P., Sampognaro, A., Phillips, E., Zhu, Y., Murray, R., Griffith, R., Blosser, J., Gurley, D., Machulskis, A., Zongrone, J., Rosen, A. & Gordon, J. (2000). J. Med. Chem. 43, 4045-4050.
8. Nonius (1999). Collect. Nonius BV, Delft, The Netherlands.
9. Otwinowski, Z. & Minor, W. (1997). Methods in Enzymology, Vol. 276, Macromolecular Crystallography, Part A, edited by C. W. Carter Jr & R. M. Sweet, pp. 307-326. New York: Academic Press.
10. Pilla, M., Perachon, S., Sautel, F., Garrido, F., Mann, A., Wermuth, C. G., Schwartz, J. C., Everitt, B. J. & Sokoloff, P. (1999). Nature (London), 400, 371-375.
11. Shafer, R. A. & Levant, B. (1998). Psychopharmacology, 135, 1-16.
12. Sheldrick, G. M. (1995). SHELXTL/PC. Version 5.03. Siemens Analytical X-ray Instruments Inc., Madison, Wisconsin, USA.
13. Sheldrick, G. M. (1997). SHELXS97 and SHELXL97. University of Göttingen, Germany.
14. Soliakov, L. & Wonnacott, S. (1996). J. Neurochem. 67, 163-170.
15. Sonar, V. N., Parkin, S. & Crooks, P. A. (2003). Acta Cryst. E59, o1478-o1480.
16. Spealman, R. D. (1990). Psychopharmacology, 101, 142-145.
17. Witkin, J. M. (1994). Neurosci. Biobehav. Rev. 18, 121-142.
18. Witkin, J. M., Schindler, C. W., Tella, S. R. & Goldberg, S. R. (1991). Psychopharmacology, 104, 425-431.
19. Xu, R., Dwoskin, L. P., Grinevich, V., Sumithran, S. P. & Crooks, P. A. (2002). Drug Dev. Res. 55, 173-186.